Removing hemp from the federal narcotics Schedule 1 list does not mean that all CBD products are now permitted, the US Food and Drug Administration (FDA) has warned.
Following passage of the Farm Bill which deschedules hemp, FDA commissioner Scott Gottlieb said that “increasing public interest in [cannabis-derived] products makes it even more important…for the FDA to clarify its regulatory authority over these products”.
That authority would continue to be exercised over food and drugs “regardless of the source of the substance, including whether the substance is derived from a plant that is classified as hemp under the Agriculture Improvement Act”, he said.
Restricted content. Do you want to read more?
Sign up NOW for 7 days FREE TRIAL and access our briefings section
CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector worldwide. Most content is available to subscribers only.
Interested in obtaining data on consumer behaviour?
Check out our new consumer survey report: CBD use in the UK market
CBD products are popular in the UK for a variety of reasons across a wide-ranging consumer base. This report offers a detailed picture of the UK CBD market, covering a range of topics such as reasons for use, length of use, consumer spending, purchase channels and user experiences and attitudes.